- Home
- EOD vs DRTS Comparison
EOD vs DRTS Comparison
Compare EOD & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EOD
- DRTS
- Stock Information
- Founded
- EOD 2007
- DRTS 2015
- Country
- EOD United States
- DRTS Israel
- Employees
- EOD N/A
- DRTS N/A
- Industry
- EOD Investment Managers
- DRTS Medical/Dental Instruments
- Sector
- EOD Finance
- DRTS Health Care
- Exchange
- EOD Nasdaq
- DRTS Nasdaq
- Market Cap
- EOD 213.8M
- DRTS 211.7M
- IPO Year
- EOD N/A
- DRTS N/A
- Fundamental
- Price
- EOD $5.17
- DRTS $2.80
- Analyst Decision
- EOD
- DRTS Strong Buy
- Analyst Count
- EOD 0
- DRTS 2
- Target Price
- EOD N/A
- DRTS $8.00
- AVG Volume (30 Days)
- EOD 118.1K
- DRTS 32.7K
- Earning Date
- EOD 01-01-0001
- DRTS 05-19-2025
- Dividend Yield
- EOD 9.28%
- DRTS N/A
- EPS Growth
- EOD N/A
- DRTS N/A
- EPS
- EOD N/A
- DRTS N/A
- Revenue
- EOD N/A
- DRTS N/A
- Revenue This Year
- EOD N/A
- DRTS N/A
- Revenue Next Year
- EOD N/A
- DRTS N/A
- P/E Ratio
- EOD N/A
- DRTS N/A
- Revenue Growth
- EOD N/A
- DRTS N/A
- 52 Week Low
- EOD $3.73
- DRTS $1.75
- 52 Week High
- EOD $4.71
- DRTS $4.39
- Technical
- Relative Strength Index (RSI)
- EOD 64.80
- DRTS 57.19
- Support Level
- EOD $5.03
- DRTS $2.57
- Resistance Level
- EOD $5.15
- DRTS $2.96
- Average True Range (ATR)
- EOD 0.08
- DRTS 0.17
- MACD
- EOD 0.02
- DRTS 0.03
- Stochastic Oscillator
- EOD 95.00
- DRTS 60.00
About EOD Allspring Global Dividend Opportunity Fund of Beneficial Interest
Allspring Global Dividend Opportunity Fund is a diversified closed-end management investment company. Its primary investment objective is to seek a high level of current income. The fund's secondary objective is the long-term growth of capital. The fund allocates its assets between two separate investment strategies or sleeves. Under normal market conditions, the fund allocates approximately 80% of its total assets to an equity sleeve comprised of common stocks.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. The Alpha CaRT technology of the company utilizes the therapeutic properties of alpha particles aiming to overcome, and harness for benefit for alpha radiation's range. The company derives maximum revenue from Israel.